I'm expecting once profitability is reached they'll be looking to sell the company around the 1p mark. Not what any of the LTHs wanted but will at leaat get most of my money back at that price.
Raising cash and hiring more people is half the equation. They need to win more contracts first which won't happen overnight. Even to double revenue to a measly £2m will take years.
The dosing tool couod be the saviour so that's still a possibility.
However if the lead scientists don't like the cut of Mr Whitlow's jib they will be soon looking for work elsewhere. I'd already be looking if it were me.